Malignant hyperthermia (MH) has been reported as non-existent in children less than 1 yr old, although several unconfirmed reports have been published. A case report of MH in a 6-monthold child is presented, with confirmation of MH susceptibility by in vitro contracture testing of quadriceps muscle at 13 yr old. Genetic analysis revealed a novel RYR1 mutation that substitutes arginine 2452 for tryptophan in a region of the calcium channel mutated in several other MH pedigrees.
Malignant hyperthermia (MH) is an inherited hypermeta-and the trachea was intubated with a size 4.0 Oxford tube.
The child breathed spontaneously a mixture of halothane, bolic disorder of skeletal muscle triggered by depolarizing muscle relaxants and potent inhalation anaesthetic agents. oxygen and nitrous oxide through a humidified T piece circuit, and was monitored using an ECG, digital plethysmoThe incidence has recently been reported as 1:50 000 anaesthetics administered in adults and 1:15 000 in chil-graph, precordial stethoscope and rectal temperature probe (capnography, agent analysis and pulse oximetry were not dren. 1 MH in infancy is considered rare 2 or even nonexistent. 3 There have been several reports indicating MH in general use at this time). Fluids were given through a 24-gauge cannula in the foot, and the patient was well reactions in infants [4] [5] [6] [7] [8] (Allen, personal communication) , but confirmation by in vitro contracture testing (IVCT) was not draped to prevent heat loss.
Anaesthesia was uneventful for the first 90 min with a demonstrated in the proband or in immediate relatives. A case report of an MH reaction in a 6-month-old child is heart rate (HR) of between 155 and 165, temperature increasing from the initial recording of 36.4°C to 37.3°C. presented, and also evidence of a novel RYR1 mutation associated with MH in this family.
Over the following 20 min his temperature increased to 38.5°C. During this time malignant hyperthermia was considered, but the diagnosis initially rejected as it was not
Case report known to occur in this age group. During the last 10 min of the case (110-120 min from the start) HR increased A 6-month-old male born at term (in 1984) following an from 160 to 190, and his temperature continued to increase, uneventful pregnancy presented for repair of complete cleft reaching 39°C. At the end of the procedure (120 min from of the right primary and secondary palate, and incomplete the start) the surgeon noted unexpected masseter muscle cleft of the left primary palate. A first stage repair using a rigidity when removing the mouth gag, and on removing modified Manchester technique was planned. There was no the drapes the patient was noted to be very flushed and family or medical history of note, he weighed 7.4 kg and sweaty. Anaesthetic agents were discontinued, respiration physical examination was normal, other than his congenital was thought to be adequate, the trachea was extubated and cleft palate.
the child taken to recovery where his temperature was He was premedicated with atropine 0.2 mg and droperidol found to be 39.5°C. Tachypnoea was then noted, blood-gas 1 mg orally 90 min before induction. An uneventful gaseous induction of anaesthesia was carried out using halothane, analysis showed a pH of 7.195, PCO 2 3.8 kPa, PO 2 13.4 kPa with a base deficit of 13.4 mmol litre -1 and a diagnosis of malignant hyperthermia was made. Dantrolene 15 mg (2 mg kg -1 ) was administered, cooling was commenced using a fan over a wet sheet, and an arterial line and urinary catheter inserted. Sodium bicarbonate, 7.5 mmol was given. Serum potassium was measured at 5.6 mmol litre -1 . The maximum temperature reached was 39.5°C 20 min after diagnosis, and 140 min following induction. The temperature returned to normal 80 min after diagnosis, 200 min from the start. No myoglobin was present in the urine and creatine kinase (CK) was initially 290 i.u., rising to 1845 i.u. (normal 0-300 i.u.) 2 h post-anaesthetic. No further therapy Fig 1 (A) Segregation of the Arg2452Trp mutation in family 1. The was required and an uneventful recovery followed. At 13 yr old the patient underwent lateral quadriceps muscle biopsy. The test was performed in accordance with the European MH Group protocol. 9 This demonstrated a strongly positive contracture (MHS) to both halothane and caffeine (6.4 g tension to 2% halothane and 5.1 g tension to caffeine 2 mmol litre -1 -nϽ0.2 g tension). The mother of the patient had a 4.3 g response to 2% halothane and a 3.7 g response to caffeine 2 mmol litre -1 , and was also diagnosed MHS. Histology of the muscle was normal. There was no evidence of myositis or recognizable dystrophy.
The proband was screened for published MH RYR1 mutations in the central mutation region of the ryanodine receptor (RYR1) gene by PCR-amplification of cDNA and automatic sequencing. None of the nine published mutations 10-15 in this region was detected. However, a novel C7354T nucleotide transition that substitutes arginine 2452 for tryptophan was identified. The mother of the proband was also positive for the Arg2452Trp mutation. The mutation was present in the DNA of one of two siblings examined, but these individuals are yet to be examined by IVCT. Segregation of the Arg2452Trp mutation in this small family (family 1) is shown in Figure 1A .
The method of 'single stranded conformational poly- (Fig. 2) . The mutation was not found in 100 normal mutation-specific SSCP bands that are absent from normal controls (lanes chromosomes indicating that it is not likely to be a common 2 and 3). DS, double-stranded DNA. polymorphism. DNA samples from MHS probands from other NZ MH families were also screened for the mutation during an emergency orthopaedic procedure. IVCT was by SSCP analysis strongly positive. The mother of this patient had a normal The Arg2452Trp mutation was not detected in the DNA IVCT (MHN), and both mother and sister were negative from 33 MHS probands examined. However, a new con-with respect to the mutation. The results of a screen for the formational variant was detected in exon 46 in one unrelated Arg2454Trp mutation in members of family 2 are presented MHS patient as shown in Fig. 2 . Sequence analysis of this in Figure 1B . second variant revealed a G7361A mutation that changes arginine 2454 to histidine. This second mutation was Discussion identified in an unrelated young male who developed a fulminant MH reaction with masseter muscle spasm, Pyrexia, increasing tachycardia, rigidity, tachypnoea, and significant metabolic acidosis as well as flushing and significant hypercapnia, tachycardia and rhabdomyolysis sweating provided clinical evidence for MH in this child. and not quadriceps, and therefore the diagnosis could be questioned. The MH clinical grading scale 17 ranks the likelihood that an adverse anaesthetic event represents MH. Points are IVCT in this case was undertaken in early teenage years, and in general we follow the policy of Ellis and coassigned to abnormal signs and laboratory findings (clinical indicators), the points are then summed to produce a raw workers 9 who established a lower age limit of 10 yr due to inconsistency in muscle responses in young children, posscore which is translated to a qualitative MH rank indicating with which likelihood MH could occur -from 1 (almost sibly related to immature muscle tissue. The size of the muscle sample to be removed and scarring are other never) to 6 (almost certain). This infant ranked 6 on this clinical grading scale. Confirmation of an MH reaction was considerations. However, Gronert 26 has found normal contracture responses in small numbers of children and other demonstrated by positive IVCT, the only reliable screening test for MH susceptibility. 18 units will test younger children. 27 If the proband is less than 10 yr old, some units will test the parents and if they Jaw rigidity was first noted by the surgeon. The anaesthetist at the time (DC) was not aware of rigidity in other are normal the child is considered normal. 9 28 However, in our unit there has been parental resistance to this procedure muscle groups. In the course of an MH reaction rigidity of the jaw usually presents as masseter muscle spasm at and a reaction could also result from a de novo mutation in the proband. induction of anaesthesia following the use of suxamethonium. In patients not given suxamethonium, muscles of the The primary event triggering MH is the abnormal release of calcium from the sarcoplasmic reticulum (SR) that chest, abdomen and extremities may be involved initially, although eventually rigidity may be generalized. 19 Isolated initiates sustained contractile and metabolic activity in skeletal muscle. 29 The SR calcium release channel was jaw rigidity in the absence of suxamethonium, 120 min after induction, may represent an alternative presentation identified as the ryanodine receptor, a large tetramer, observed as the 'foot' structure spanning the junctional SR of MH in an infant.
Management of the reaction proceeded with few prob-and surface membranes. 30 Abnormalities in the regulation of calcium release from the ryanodine receptor were revealed lems. Dantrolene was administered in a dose of 2 mg kg -1 which is lower than the recommended starting dose of in studies of skeletal muscle from MHS pigs and humans. 31 In 1990, McCarthy and co-workers 32 identified the ryano-2.4 mg kg -1 . 20 Lerman found normal metabolism of dantrolene in young children and a dose of 2.4 mg kg -1 produces dine receptor gene (RYR1) as a likely candidate for the MHS locus, and in the subsequent 9 yr the role of RYR1 safe and predictable blood concentrations. Reconstituted dantrolene, pH 9-10, is irritant to veins and in an infant has been confirmed with the discovery of numerous RYR1 mutations in MH families. 13 The Arg2452Trp mutation should be injected into a fast-running intravenous infusion or large central vein. 21 Intraosseous administration provides described in this report takes the number of published MH/ central core disease mutations in the RYR1 gene to 20. an alternative route if venous access is problematic.
Reactions in infants younger than 6 months have not RYR1 mutations may underlie only 50% of cases of MH susceptibility, 33 and defects in any number of proteins been previously proven. There have been several reports of MH reactions in the newborn associated with the stress of involved in myoplasmic calcium homeostasis may be commonly expressed as the MH syndrome. In fact, genetic labour, but alternative aetiologies for these reactions could be proposed. [21] [22] [23] At our institution MH suspect newborn heterogeneity in MH is now firmly established with the description of five additional MH loci on chromosomes are monitored for 4 h with pulse, ventilatory frequency and temperature, and no significant abnormalities have been 17q, 7q, 3q, 1q and 5p. [34] [35] [36] [37] [38] The emerging complexity of MH genetics excludes the development of a general genetic reported in 66 infants born to MHS or mothers related to MHS individuals (Langton, unpublished observations). test to replace the IVCT in the near future. There are several reports of MHS diagnoses in individuals who are negative Reactions associated with farrowing have not been reported in susceptible piglets. There may in fact be resistance to for a particular mutation segregating in their family 11 39-41 suggestive of either false positive IVCT or the occurrence the development of MH in the neonatal period and early infancy. Fay and Gallant 24 found that MHS piglets had of additional MH genes. Consequently, genetic testing cannot safely replace the IVCT to establish MHN status. delayed reactions when exposed to triggering agents, and in vitro responses were not as pronounced as the contractures
We have searched for the published mutations in the central RYR1 region by automatic sequencing of compleusually observed in muscle from older MHS pigs. These findings were confirmed by Wedel. 2 mentary DNA (cDNA), using skeletal muscle tissue excised for IVCT. RNA was extracted from frozen muscle tissue As indicated earlier, several case reports in infants younger than 6 months have been published in the anaes-and used as a template to synthesize the cDNA. Because the cDNA comprises only the coding region of a gene, thetic literature, but with the exception of Faust and coworkers, 25 IVCT was not performed. In this latter case this approach allows efficient simultaneous screening for clustered RYR1 mutations, as well as enabling detection of triggering agents were not administered, the reaction ranked 3 or 'somewhat less than likely' on the MH clinical grading any novel mutations. A novel arginine 2452 to tryptophan RYR1 mutation was identified in this patient. The mutation scale and IVCT was performed from sterno-mastoid muscle 
